Genomic studies to unlock
the truth of active compounds

Genel provides pharmaceutical and cosmetic companies
with new services to enhance personalized care.
Genel proposes innovative approach:

using 3D cellular models and primary cells to highlight active ingredient effects on its gene target
combining bioscreening, new imaging system and bioinformatics to guarantee an effective, fast, reliable and ready-to-use result

Pharma
Cosmetics

New GenDetox test
New GenDetox test
Grenoble | 12 July 2016

In the countryside, in towns, pollution is in every place. Our skin is damaged every day by organic compounds, fine particles, heavy metals, emission gases,...


COSMINNOV 2016
COSMINNOV 2016
ORLEANS | 24-25 May 2016

COSM’innov is the venue for discovering the latest advances in cosmetology’s main scientific disciplines. Come and see us at the poster session to learn...


In-Cosmetics
In-Cosmetics
Paris | 12-14 April 2016

in cosmetics is the global launch pad for innovations in ingredients and technologies, delivering high-level scientific education and consumer insights for...


L’épigénétique dans la mélanogenèse
L’épigénétique dans la mélanogenèse
Grenoble | 19 January 2016

Une tendance durable : avoir un teint lumineux et lisse. Comment faire pour que notre peau paraisse naturellement éclatante ? La beauté du teint, preuve de...


Genel, lauréate 2015 du Trophée R2B Onco
Genel, lauréate 2015 du Trophée R2B Onco
Lyon | 24 November 2015

Neolys Diagnostics (Lyon) et Genel (Grenoble), deux jeunes sociétés de biotechnologies, ont été récompensées le 24 novembre à Lyon du trophée R2B ONCO...

Genel: Innovation
The key to performance